PR Newswire Europe - U.S. Regulators Approve Cymbalta(R) for Treatment of Generalised Anxiety Disorder.
Sunday, January 4th, 2009 INDIANAPOLIS, February 26 /PRNewswire/ —
The U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta(R) (duloxetine HCl) for the treatment of generalised anxiety disorder (GAD), Eli Lilly and Company (NYSE: LLY) and Boehring…
